Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
calcitonin gene-related peptide
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
chronic migraine
detroit blog main
detroit top stories
drugs
episodic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
migraine
migraine research foundation
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
What
approval
3
×
class
3
×
drug
fda
migraine
new
3
×
won
developed
medicines
pain
starts
amgen
announced
approved
arguments
big
candidates
commercialized
companies
competitors
decades
decision
drugs
eli
gets
head
headache
late
lilly
make
marks
meeting
neuro
nod
oral
potential
prevent
preventive
therapies
thursday
Language
Current search:
class
×
new
×
approval
×
amgen
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines